Strategies in the Global Nucleic Acid Testing Market 2015-2020

    


This unique seven-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years.

Highlights

- Business and technological trends in seven major markets
- Five- and ten-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing innovative technologies and products
- Specific product and business opportunities for instrument and consumable suppliers.

Worldwide Market Overview

- Laboratories performing DNA sequencing and NAT by country and market segment.
- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of major suppliers of NAT reagent kits and components.
- Ten-year test volume and sales forecasts for major applications

Market Segmentation Analysis including review of the market dynamics, trends, structure, size, growth and major suppliers, by country.

Product/Technology Review

- Comparison of leading NAT analyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

Extensive review of NAT technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:

- PCR
- bDNA
- SDA
- NASBA
- TMA
- SSSR, and others
- LCR
- Worldwide listings of companies, universities and research centers developing new NAT technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
- Comprehensive listings of companies developing and marketing NAT products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next ten years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.

For more information visit http://www.researchandmarkets.com/research/twz4hb/2015_strategies

Media Contact: Laura Wood , +353-1-481-1716, [email protected]